Cytokinetics (CYTK) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Cytokinetics Revenue Highlights

Latest Revenue (Y)

$88.04M

Latest Revenue (Q)

$66.77M

Main Segment (Y)

Collaboration Revenues

Main Geography (Y)

CHINA

Cytokinetics Revenue by Period

Cytokinetics Revenue by Year

Date	Revenue	Change
2025-12-31	$88.04M	376.56%
2024-12-31	$18.47M	145.34%
2023-12-31	$7.53M	-92.04%
2022-12-31	$94.59M	34.30%
2021-12-31	$70.43M	26.15%
2020-12-31	$55.83M	107.79%
2019-12-31	$26.87M	-14.71%
2018-12-31	$31.50M	135.64%
2017-12-31	$13.37M	-87.44%
2016-12-31	$106.41M	271.30%
2015-12-31	$28.66M	-38.95%
2014-12-31	$46.94M	53.16%
2013-12-31	$30.65M	305.45%
2012-12-31	$7.56M	88.97%
2011-12-31	$4.00M	55.22%
2010-12-31	$2.58M	-96.84%
2009-12-31	$81.54M	556.51%
2008-12-31	$12.42M	-8.82%
2007-12-31	$13.62M	335.63%
2006-12-31	$3.13M	-64.91%
2005-12-31	$8.91M	-33.70%
2004-12-31	$13.44M	27.09%
2003-12-31	$10.58M	-7.19%
2002-12-31	$11.40M	34.61%
2001-12-31	$8.47M	100.00%
2000-12-31	-	-

Cytokinetics generated $88.04M in revenue during NA 2025, up 376.56% compared to the previous quarter, and up 157.70% compared to the same period a year ago.

Cytokinetics Revenue by Quarter

Date	Revenue	Change
2025-06-30	$66.77M	4128.56%
2025-03-31	$1.58M	-90.67%
2024-12-31	$16.93M	3555.94%
2024-09-30	$463.00K	85.94%
2024-06-30	$249.00K	-70.18%
2024-03-31	$835.00K	-50.06%
2023-12-31	$1.67M	342.33%
2023-09-30	$378.00K	-56.40%
2023-06-30	$867.00K	-81.21%
2023-03-31	$4.61M	135.72%
2022-12-31	$1.96M	-22.19%
2022-09-30	$2.52M	-97.17%
2022-06-30	$88.97M	7649.83%
2022-03-31	$1.15M	-97.94%
2021-12-31	$55.60M	922.62%
2021-09-30	$5.44M	91.24%
2021-06-30	$2.84M	-56.58%
2021-03-31	$6.55M	-2.59%
2020-12-31	$6.72M	-83.88%
2020-09-30	$41.69M	1060.26%
2020-06-30	$3.59M	-6.07%
2020-03-31	$3.83M	-26.61%
2019-12-31	$5.21M	-13.92%
2019-09-30	$6.05M	-15.16%
2019-06-30	$7.14M	-15.68%
2019-03-31	$8.46M	-9.74%
2018-12-31	$9.38M	-11.88%
2018-09-30	$10.64M	71.21%
2018-06-30	$6.21M	17.98%
2018-03-31	$5.27M	-29366.67%
2017-12-31	$-18.00K	-100.29%
2017-09-30	$6.18M	102.42%
2017-06-30	$3.05M	-26.49%
2017-03-31	$4.15M	-87.47%
2016-12-31	$33.14M	-43.88%
2016-09-30	$59.05M	917.70%
2016-06-30	$5.80M	-31.10%
2016-03-31	$8.42M	-13.69%
2015-12-31	$9.76M	22.81%
2015-09-30	$7.95M	21.45%
2015-06-30	$6.54M	48.21%
2015-03-31	$4.41M	-79.71%
2014-12-31	$21.76M	131.10%
2014-09-30	$9.41M	20.89%
2014-06-30	$7.79M	-2.39%
2014-03-31	$7.98M	-67.23%
2013-12-31	$24.35M	444.84%
2013-09-30	$4.47M	342.91%
2013-06-30	$1.01M	22.90%
2013-03-31	$821.00K	-62.41%
2012-12-31	$2.18M	27.42%
2012-09-30	$1.71M	-6.90%
2012-06-30	$1.84M	1.15%
2012-03-31	$1.82M	140.42%
2011-12-31	$757.00K	-46.95%
2011-09-30	$1.43M	35.52%
2011-06-30	$1.05M	38.01%
2011-03-31	$763.00K	-30.57%
2010-12-31	$1.10M	178.93%
2010-09-30	$394.00K	-14.72%
2010-06-30	$462.00K	-25.60%
2010-03-31	$621.00K	-39.30%
2009-12-31	$1.02M	-81.42%
2009-09-30	$5.51M	-92.35%
2009-06-30	$71.93M	2236.91%
2009-03-31	$3.08M	-2.35%
2008-12-31	$3.15M	0.86%
2008-09-30	$3.13M	1.66%
2008-06-30	$3.07M	0.16%
2008-03-31	$3.07M	-1.32%
2007-12-31	$3.11M	-

Cytokinetics generated $66.77M in revenue during Q2 2025, up 4128.56% compared to the previous quarter, and up 7996.29% compared to the same period a year ago.

Cytokinetics Revenue Breakdown

Cytokinetics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Collaboration Revenues	$8.69M	$3.47M	-	-	-
License	-	-	-	-	-
Milestone	-	-	$3.50M	$1.00M	-
Research And Development	-	-	$4.03M	$6.59M	$10.57M
Research And Development Milestone Grant And Other Revenues Net	-	-	-	-	$7.40M

Cytokinetics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Collaboration Revenues (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20
Collaboration Revenues	$4.33M	$1.94M	$2.42M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development	-	-	-	$463.00K	$835.00K	$672.00K	$378.00K	$867.00K	$2.11M	$1.96M	$2.52M	$968.00K	$1.15M	$744.00K	$437.00K	$2.84M	$6.55M	$3.92M	$5.19M	$3.59M
Milestone	-	-	-	-	-	$1.00M	-	-	$2.50M	-	-	$1.00M	-	-	-	-	-	-	-	-
License	-	-	-	-	-	-	-	-	-	-	-	-	-	$54.86M	-	-	-	-	-	-
Milestones	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$5.00M	-	-	-	-	-
Research And Development Milestone Grant And Other Revenues Net	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.50M	$4.80M	$1.70M	$3.80M	$2.10M

Cytokinetics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Collaboration Revenues (100.00%).

Cytokinetics Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25
CHINA	$600.00K

Cytokinetics's latest annual revenue breakdown by geography, as of Dec 25: CHINA (100.00%).

Quarterly Revenue by Country

Country	Dec 25	Sep 25	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
CHINA	$200.00K	$400.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development	-	-	$867.00K	$2.11M	$1.96M	$2.52M	$968.00K	$1.15M	$744.00K	$437.00K	$2.84M	$6.55M	$3.92M	$5.19M	$3.59M	$3.83M	$5.21M	$6.05M	$7.14M	$8.46M
Milestone	-	-	-	$2.50M	-	-	$1.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
License	-	-	-	-	-	-	-	-	$54.86M	-	-	-	-	-	-	-	-	-	-	-
Milestones	-	-	-	-	-	-	-	-	-	$5.00M	-	-	-	-	-	-	-	-	-	-
Research And Development Milestone Grant And Other Revenues Net	-	-	-	-	-	-	-	-	-	-	$2.50M	$4.80M	$1.70M	$3.80M	$2.10M	$2.30M	-	-	-	-

Cytokinetics's latest quarterly revenue breakdown by geography, as of Dec 25: CHINA (100.00%).

Cytokinetics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
JAZZ	Jazz Pharmaceuticals	$4.27B	$1.05B
HALO	Halozyme Therapeutics	$1.40B	$354.26M
CORT	Corcept Therapeutics	$761.41M	$207.64M
AXSM	Axsome Therapeutics	$638.50M	$170.99M
RYTM	Rhythm Pharmaceuticals	$189.76M	$51.30M
CYTK	Cytokinetics	$88.04M	$66.77M
MRUS	Merus	$36.13M	$12.15M
CRSP	CRISPR Therapeutics	$3.51M	$889.00K
NUVL	Nuvalent	-	-
MTSR	Metsera	-	-
ABVX	Abivax	-	-

CYTK Revenue FAQ

What is Cytokinetics’s yearly revenue?

Cytokinetics's yearly revenue for 2025 was $88.04M, representing an increase of 376.56% compared to 2024. The company's yearly revenue for 2024 was $18.47M, representing an increase of 145.34% compared to 2023. CYTK's yearly revenue for 2023 was $7.53M, representing a decrease of -92.04% compared to 2022.

What is Cytokinetics’s quarterly revenue?

Cytokinetics's quarterly revenue for Q2 2025 was $66.77M, a 4128.56% increase from the previous quarter (Q1 2025), and a 26714.86% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $1.58M, a -90.67% decrease from the previous quarter (Q4 2024), and a 89.10% increase year-over-year (Q1 2024). CYTK's quarterly revenue for Q4 2024 was $16.93M, a 3555.94% increase from the previous quarter (Q3 2024), and a 912.38% increase year-over-year (Q4 2023).

What is Cytokinetics’s revenue growth rate?

Cytokinetics's revenue growth rate for the last 3 years (2023-2025) was 1069.18%, and for the last 5 years (2021-2025) was 25.01%.

What are Cytokinetics’s revenue streams?

Cytokinetics's revenue streams in c 25 are Collaboration Revenues

What is Cytokinetics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Cytokinetics was Collaboration Revenues. This segment made a revenue of $8.69M, representing 100.00% of the company's total revenue.